Recovering from an acute ischemic stroke, which is a blockage in the brain's blood supply, is a difficult journey. For many, the goal is to return to independence after undergoing endovascular therapy, a procedure used to clear the blockage. But what determines if a person will regain their function or face lasting disability?
A study of 213 patients found that levels of TMAO, a compound produced by gut bacteria, are linked to poorer outcomes three months after treatment. Specifically, higher levels of this gut-derived substance were associated with a higher risk of having a poor functional outcome.
The researchers also looked at other factors like age and the severity of the stroke at baseline. While older age and higher initial stroke severity were also linked to worse results, the connection to TMAO levels was particularly notable.
It is important to remember that this was a retrospective study, meaning researchers looked back at existing patient data to find these links. Because of this design, the study shows an association rather than proving that TMAO directly causes poor recovery.
